The Claim
In Japanese adults with type 2 diabetes, serum bilirubin concentration is not associated with subcutaneous fat area, indicating that its relationship with fat distribution is specific to visceral adipose tissue.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Japanese adults with type 2 diabetes, levels of bilirubin in the blood show no link to the amount of fat under the skin, but are linked specifically to fat around internal organs.
See the scientific wording
In Japanese adults with type 2 diabetes, serum bilirubin concentration is not associated with subcutaneous fat area, suggesting its relationship with fat distribution is specific to visceral adipose tissue.
Bilirubin lowers harmful fat buildup around organs by turning off a cellular stress system that causes inflammation, while also helping fat cells grow normally instead of becoming large and dysfunctional. This reduces inflammation and lets insulin work better, but it does not affect fat under the skin.
What the research says
1 studyStudy: Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
In people with type 2 diabetes, higher bilirubin levels are linked to less fat around the organs, but not to fat just under the skin — so bilirubin seems to specifically target belly fat, not all fat.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.